These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9684919)

  • 1. The serotonin syndrome scale: first results on validity.
    Hegerl U; Bottlender R; Gallinat J; Kuss HJ; Ackenheil M; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(2):96-103. PubMed ID: 9684919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment.
    Zourková A; Hadasová E
    J Sex Marital Ther; 2002; 28(5):451-61. PubMed ID: 12378847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol].
    Llinares-Tello F; Escrivá-Moscardó S; Martínez-Pastor F; Martínez-Mascaraque P
    Med Clin (Barc); 2007 Mar; 128(11):438. PubMed ID: 17394862
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus on paroxetine.
    Green B
    Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine treatment of trichotillomania in an adolescent.
    Block C; West SA; Baharoglu B
    J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.
    Polimeni G; Grugno R; Cordici F; Vitetta A; Caputi AP; Bramanti P
    J Clin Psychopharmacol; 2008 Oct; 28(5):589-91. PubMed ID: 18794668
    [No Abstract]   [Full Text] [Related]  

  • 10. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?
    Hegerl U; Gallinat J; Juckel G
    J Affect Disord; 2001 Jan; 62(1-2):93-100. PubMed ID: 11172876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics.
    Kim JR; Woo HI; Chun MR; Lim SW; Kim HD; Na HS; Chung MW; Myung W; Lee SY; Kim DK
    Drug Des Devel Ther; 2015; 9():5247-54. PubMed ID: 26396498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
    JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorder.
    Lee BH; Park YM; Lee SH; Shim M
    Int J Mol Sci; 2015 Mar; 16(3):6251-65. PubMed ID: 25794285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials.
    Park YM
    Psychopharmacology (Berl); 2014 Feb; 231(3):551-5. PubMed ID: 24005532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 17. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.
    Wutzler A; Winter C; Kitzrow W; Uhl I; Wolf RJ; Heinz A; Juckel G
    Neuropsychopharmacology; 2008 Dec; 33(13):3176-81. PubMed ID: 18463629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of serotonergic agents resulted in severe adverse effects].
    Jägestedt M; von Bahr C
    Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
    Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do you treat patients with Seroxat?].
    Allgulander C
    Lakartidningen; 2003 Jul; 100(28-29):2398. PubMed ID: 12899040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.